SCHEMBL30488017

SCHEMBL30488017

CN1CCN(CCOc2ccc(-c3cc(N)nc(N)n3)cc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.58
MAOB P27338 2/20 0.58
BCHE P06276 1/20 0.58
MAOA P21397 1/20 0.58
CXCR1 P25024 5/20 0.54
DYRK1A Q13627 1/20 0.53
HRH4 Q9H3N8 3/20 0.52
ADORA2A P29274 1/20 0.49
ADORA1 P30542 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
LTA4H P09960 1/20 0.48
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2C P18825 1/20 0.46
HTR1D P28221 1/20 0.46
HTR2A P28223 1/20 0.46
HTR2C P28335 1/20 0.46
HTR7 P34969 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28589976 1.00 ACHE (0.58) ACHEMAOBBCHEMAOACXCR1
SCHEMBL30488024 0.76 DYRK1A (0.60) ACHEMAOBBCHEMAOADYRK1A
SCHEMBL28589316 0.76 DYRK1A (0.60) ACHEMAOBBCHEMAOADYRK1A
SCHEMBL30488027 0.76 DYRK1A (0.60) ACHEMAOBBCHEMAOADYRK1A
SCHEMBL28586035 0.76 BMP4 (0.50) CXCR1ADORA2AADORA1NPC1RAB9A
SCHEMBL28600101 0.76 DYRK1A (0.60) ACHEMAOBBCHEMAOADYRK1A
SCHEMBL30488037 0.76 DYRK1A (0.60) ACHEMAOBBCHEMAOADYRK1A
SCHEMBL76551 0.75 LTA4H (0.69) NPC1RAB9ALTA4HHRH3
SCHEMBL31436945 0.73 RAB9A (0.54) CXCR1NPC1RAB9ALTA4HHRH3
SCHEMBL4080135 0.73 LTA4H (0.56) ACHEMAOBBCHEMAOALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113061116-B Aminopyrimidine compound, preparation method, composition and application thereof 上海医药工业研究院 2023-07-25 CN disclosed